The prognosis for patients with palmoplantar psoriasis is guarded. The treatments often take a long time to work, have adverse effects and are costly. The quality of life of most patients is poor. Most patients need combination therapy for many months before they see a response. In addition, patients also have other comorbidities that affect prognosis.